FDA Approves Retevmo for Some With Medullary Thyroid Cancer
The FDA has approved Retevmo for select pediatric and adult patients with medullary thyroid cancer who have RET mutations. The ...
Tag: food and drug administration
FDA Approves Tagrisso for Some With Advanced NSCLC
Tagrisso was approved by the FDA for certain patients with stage 3 non-small cell lung cancer.The Food and Drug Administration ...
FDA Approves Kisqali Regimen for HR+/HER2- Early Breast Cancer
The FDA has approved Kisqali plus an aromatase inhibitor for patients with HR-positive, HER2-negative early breast cancer. The Food and ...
A New Era in Small Cell Lung Cancer Treatment
Dr. Debu Tripathy, editor-in-chief of CURE magazineAlthough advancements in treatments for small cell lung cancer (SCLC) are scarce for this ...
Treatment Breakthroughs Arrive for SCLC
Photography by Jill StifflerFor Sabrina Potts, the approval by the Food and Drug Administration (FDA) of Imdelltra (tarlatamab-dlle) in May ...